Clinical trial
Assessment of the Role of Diffusion MRI Changes During Chemoradiation Treatment of Head and Neck Cancer
NCT04251481 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of the Role of Diffusion MRI Changes During Chemoradiation Treatment of Head and Neck Cancer
- Lead sponsor
- NYU Langone Health
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 16, 2019
- Completion date
- April 30, 2026
- Enrollment
- 16 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
head cancer neck